Join

Compare · POLA vs TMO

POLA vs TMO

Side-by-side comparison of Polar Power Inc. (POLA) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.

Summary

  • POLA operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
  • TMO is the larger of the two at $174.49B, about 27869.0x POLA ($6.3M).
  • Over the past year, POLA is down 16.4% and TMO is up 11.5% - TMO leads by 27.9 points.
  • TMO has been more active in the news (6 items in the past 4 weeks vs 1 for POLA).
  • TMO has more recent analyst coverage (25 ratings vs 0 for POLA).
PerformancePOLA-16.43%TMO+11.45%
2025-04-28+0.00%2026-04-24
MetricPOLATMO
Company
Polar Power Inc.
Thermo Fisher Scientific Inc
Price
$1.73+1.76%
$469.57+0.63%
Market cap
$6.3M
$174.49B
1M return
+1.76%
-4.31%
1Y return
-16.43%
+11.45%
Industry
Industrial Machinery/Components
Industrial Machinery/Components
Exchange
NASDAQ
NYSE
IPO
2016
News (4w)
1
6
Recent ratings
0
25
POLA

Polar Power Inc.

Polar Power, Inc. designs, manufactures, and sells direct current (DC), power generators, renewable energy, and cooling systems in the United States and internationally. It offers DC base power systems, DC hybrid power systems, and DC solar hybrid power systems. The company serves customers in the telecommunications, military, commercial, industrial, and marine markets. It sells its products through direct sales force, and a network of independent service providers and dealers. The company was formerly known as Polar Products, Inc. and changed its name to Polar Power, Inc. in October 1991. Polar Power, Inc. was incorporated in 1979 and is based in Gardena, California.

TMO

Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.

Latest POLA

Latest TMO